Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Power Graphic](https://lunarcrush.com/gi/w:26/t:power.png) Power

There's growing interest in the potential of certain molecules, such as those being developed by $ABCL, to treat various conditions, including multiple sclerosis and cancer. Researchers are exploring new approaches, including remyelination and metabolic therapy, to address these diseases. Clinical trial success is crucial, but challenges like missing data and the nocebo effect can impact outcomes.

### About Power
Power refers to the biotech industry and related advancements in medical research and clinical trials.  

### Engagements: XXX [#](/topic/power/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:power/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/power/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXXXX +433%  
**6 Months**: XXXXXXX +22%  
**1 Year**: XXXXXXX +18%  
**1-Year High**: XXXXXXX on 2025-02-06  
**1-Year Low**: X on 2024-11-06  

| Social Network | X   | YouTube |
| -------------- | -   | ------- |
| Engagements    | XXX | XXX     |
  

  
  
### Mentions: X [#](/topic/power/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:power/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/power/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X -XX%  
**1 Month**: XX -XX%  
**6 Months**: XXX +68%  
**1 Year**: XXX +239%  
**1-Year High**: XX on 2025-08-14  
**1-Year Low**: X on 2024-10-26  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | XX      |
  

  
  
### Creators: X [#](/topic/power/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:power/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/power/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning Power in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: XX -XX%  
**1 Month**: XX -XX%  
**6 Months**: XXX +86%  
**1 Year**: XXX +177%  
**1-Year High**: XX on 2025-10-11  
**1-Year Low**: X on 2024-10-26  
  
  
### Sentiment: XX% [#](/topic/power/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:power/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/power/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +25%  
**6 Months**: XXX% no change  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2024-10-24  
**1-Year Low**: XX% on 2024-11-22  

**Most Supportive Themes**
- **Neura Protocol and $ABCL Advancements:** (60%) Posts highlight Neura Protocol's backing and potential, along with $ABCL's clinical trial prospects.
- **Medical Research and Clinical Trials:** (30%) Posts discuss advancements in medical research, including topics like retrospective studies, MS symptom reversal, and cancer survival.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %  |
| ------- | -------- | -  | ------- | -  | -------- | -  |
| X       | XX       | X% |         |    |          |    |
| YouTube | X        | X% | X       | X% | XX       | X% |
|         |          |    |         |    |          |    |
| Total   | XX       | X% | X       | X% | X        | X% |
  


**Top assets mentioned**
In the posts about Power in the last XX hours

[Innovative Solutions & Support (ISSC)](/topic/$issc)

**Top topics mentioned**
In the posts about Power in the last XX hours

[$abcl](/topic/$abcl), [applications](/topic/applications), [$issc](/topic/$issc)

### Top Social Posts [#](/topic/power/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan"  
[YouTube Link](https://youtube.com/watch?v=9GXMd57tuL4) [@powertothepatients](/creator/youtube/powertothepatients) 2025-10-22T11:52Z XX followers, X engagements


"Missing Data Is a DANGER to Every Clinical Trial"  
[YouTube Link](https://youtube.com/watch?v=j751plgBQe8) [@pragmatictrialstraining](/creator/youtube/pragmatictrialstraining) 2025-10-20T16:15Z XX followers, XX engagements


"The Surprising Science of the Nocebo Effect 🤯"  
[YouTube Link](https://youtube.com/watch?v=5FcME9_Lzo4) [@viral](/creator/youtube/viral) 2025-10-20T13:03Z 5000 followers, XXX engagements


"$ABCL is positioned to see an exponential increase in earning power as/if its X molecules succeed in clinical trials. These molecules have MASSIVE end applications beyond the conditions being trialed at present which creates huge asymmetry"  
[X Link](https://x.com/alc2022/status/1973408821654557086) [@alc2022](/creator/x/alc2022) 2025-10-01T15:25Z 107.9K followers, 47.5K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Power Graphic Power

There's growing interest in the potential of certain molecules, such as those being developed by $ABCL, to treat various conditions, including multiple sclerosis and cancer. Researchers are exploring new approaches, including remyelination and metabolic therapy, to address these diseases. Clinical trial success is crucial, but challenges like missing data and the nocebo effect can impact outcomes.

About Power

Power refers to the biotech industry and related advancements in medical research and clinical trials.

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXXX +433%
6 Months: XXXXXXX +22%
1 Year: XXXXXXX +18%
1-Year High: XXXXXXX on 2025-02-06
1-Year Low: X on 2024-11-06

Social Network X YouTube
Engagements XXX XXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: XX -XX%
6 Months: XXX +68%
1 Year: XXX +239%
1-Year High: XX on 2025-08-14
1-Year Low: X on 2024-10-26

Social Network X YouTube
Mentions XX XX

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Power in the last XX hours which is up XX% from X in the previous XX hours Daily Average: X
1 Week: XX -XX%
1 Month: XX -XX%
6 Months: XXX +86%
1 Year: XXX +177%
1-Year High: XX on 2025-10-11
1-Year Low: X on 2024-10-26

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +25%
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-10-24
1-Year Low: XX% on 2024-11-22

Most Supportive Themes

  • Neura Protocol and $ABCL Advancements: (60%) Posts highlight Neura Protocol's backing and potential, along with $ABCL's clinical trial prospects.
  • Medical Research and Clinical Trials: (30%) Posts discuss advancements in medical research, including topics like retrospective studies, MS symptom reversal, and cancer survival.

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX X%
YouTube X X% X X% XX X%
Total XX X% X X% X X%

Top assets mentioned In the posts about Power in the last XX hours

Innovative Solutions & Support (ISSC)

Top topics mentioned In the posts about Power in the last XX hours

$abcl, applications, $issc

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan"
YouTube Link @powertothepatients 2025-10-22T11:52Z XX followers, X engagements

"Missing Data Is a DANGER to Every Clinical Trial"
YouTube Link @pragmatictrialstraining 2025-10-20T16:15Z XX followers, XX engagements

"The Surprising Science of the Nocebo Effect 🤯"
YouTube Link @viral 2025-10-20T13:03Z 5000 followers, XXX engagements

"$ABCL is positioned to see an exponential increase in earning power as/if its X molecules succeed in clinical trials. These molecules have MASSIVE end applications beyond the conditions being trialed at present which creates huge asymmetry"
X Link @alc2022 2025-10-01T15:25Z 107.9K followers, 47.5K engagements

Power
/topic/power